Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system

References

• Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):e004365.
   PubMed Web of Science ®Google Scholar
• Zafeiri A, Mitchell RT, Hay DC, et al. Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety. Hum Reprod Update. 2021;27(1):67–95.
   PubMed Web of Science ®Google Scholar
• Ray-Griffith SL, Wendel MP, Stowe ZN, et al. Chronic pain during pregnancy: a review of the literature. Int J Womens Health. 2018;10:153–164.
   PubMed Web of Science ®Google Scholar
• Del Papa N, Vaso N. Management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis. 2010;2(4):221–227.
   PubMedGoogle Scholar
• Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287–293 e1.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2020.DOI:10.1016/j.ajog.2020.08.045
   Google Scholar
• Poon LC, Sahota D. Screening and prevention of preeclampsia. Maternal-Fetal Medicine. 2019;1(1):25–30.
   Google Scholar
• Rebordosa C, Kogevinas M, Horvath-Puho E, et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obstet Gynecol. 2008;198(2):178–177.
   PubMed Web of Science ®Google Scholar
• Kozer E, Nikfar S, Costei A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002;187(6):1623–1630.
   PubMed Web of Science ®Google Scholar
• Dathe K, Fietz AK, Pritchard LW, et al. No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – evaluation of the national embryotox cohort. Reprod Toxicol. 2018;79:32–38.
   PubMed Web of Science ®Google Scholar
• Bisson DL, Newell SD, Laxton C. Antenatal and postnatal analgesia: Scientific impact paper no. 59. BJOG. 2019;126(4):e114–e124.
   PubMed Web of Science ®Google Scholar
• Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Prenatal acetaminophen use and outcomes in children. Am J Obstet Gynecol. 2017;216(3):B14–B15.
   PubMedGoogle Scholar
• Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157C(3):175–182.
   PubMed Web of Science ®Google Scholar
• Slone D, Siskind V, Heinonen OP, et al. Aspirin and congenital malformations. Lancet. 1976;1(7974):1373–1375.
   PubMed Web of Science ®Google Scholar
• Lynberg MC, Khoury MJ, Lu X, et al. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol. 1994;140(3):244–255.
   PubMed Web of Science ®Google Scholar
• Warkany J, Takacs E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 1959;35(2):315–331.
   PubMed Web of Science ®Google Scholar
• Hertz-Picciotto I, Hopenhayn-Rich C, Golub M, et al. The risks and benefits of taking aspirin during pregnancy. Epidemiol Rev. 1990;12:108–148.
   PubMed Web of Science ®Google Scholar
• Larsson KS, Bostrom H, Ericson B. Salicylate-Induced malformations in mouse Embryos1. Acta Paediatrica. 1963;52(1):36–40.
   Web of Science ®Google Scholar
• Brandlistuen RE, Ystrom E, Nulman I, et al. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42(6):1702–1713.
   PubMed Web of Science ®Google Scholar
• Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313–320.
   PubMed Web of Science ®Google Scholar
• Liew Z, Ritz B, Virk J, et al. Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish National Birth Cohort Study. Autism Res. 2016;9(9):951–958.
   PubMed Web of Science ®Google Scholar
• Alemany S, Avella-Garcia C, Liew Z, et al. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: meta-analysis in six European population-based cohorts. Eur J Epidemiol. 2021;36(10):993–1004.
   PubMed Web of Science ®Google Scholar
• Petersen TG, Liew Z, Andersen AN, et al. Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child. Int J Epidemiol. 2018;47(1):121–130.
   PubMed Web of Science ®Google Scholar
• Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int. 2012;2012:796590.
   PubMedGoogle Scholar
• Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–214.
   PubMed Web of Science ®Google Scholar
• Liang B, Wang CC. Morphology-based whole embryo culture for developmental toxicity of drugs. Methods Mol Biol. 2018;1797:177–189.
   PubMedGoogle Scholar
• Pryor SE, Massa V, Savery D, et al. Convergent extension analysis in mouse whole embryo culture. Methods Mol Biol. 2012;839:133–146.
   PubMedGoogle Scholar
• Chan AOK, Dong M, Wang L, et al. Somite as a morphological reference for staging and axial levels of developing structures in mouse embryos. Neuroembryol Aging. 2004;3(2):102–110.
   Google Scholar
• Van Maele-Fabry G, Delhaise F, Picard JJ. Morphogenesis and quantification of the development of post-implantation mouse embryos. Toxicol in Vitro. 1990;4(2):149–156.
   PubMed Web of Science ®Google Scholar
• Oskoui M, Coutinho F, Dykeman J, et al. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013;55(6):509–519.
   PubMed Web of Science ®Google Scholar
• Stavsky M, Mor O, Mastrolia SA, et al. Cerebral Palsy-Trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention. Front Pediatr. 2017;5(21):21.
   PubMedGoogle Scholar
• Sinha G, Corry P, Subesinghe D, et al. Prevalence and type of cerebral palsy in a British Ethnic Community: the role of consanguinity. Dev Med Child Neurol. 1997;39(4):259–262.
   PubMed Web of Science ®Google Scholar
• Hjern A, Thorngren-Jerneck K. Perinatal complications and socio-economic differences in cerebral palsy in Sweden – a national cohort study. BMC Pediatr. 2008;8(1):49.
   PubMedGoogle Scholar
• Johnson A. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002;44(09):633–640.
   PubMedGoogle Scholar
• Demeši Drljan Č, Mikov A, Filipović K, et al. Cerebral palsy in preterm infants. VSP. 2016;73(4):343–348.
   Google Scholar
• Dahlseng MO, Andersen GL, Irgens LM, et al. Risk of cerebral palsy in term-born singletons according to growth status at birth. Dev Med Child Neurol. 2014;56(1):53–58.
   PubMed Web of Science ®Google Scholar
• Mor O, Stavsky M, Yitshak-Sade M, et al. Early onset preeclampsia and cerebral palsy: a double hit model? Am J Obstet Gynecol. 2016;214(1):105 e1–9.
   PubMed Web of Science ®Google Scholar
• Tronnes H, Wilcox AJ, Lie RT, et al. Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study. Dev Med Child Neurol. 2014;56(8):779–785.
   PubMed Web of Science ®Google Scholar
• Strand KM, Heimstad R, Iversen AC, et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study. Bmj. 2013;347(jul09 2):f4089–f4089.
   PubMedGoogle Scholar
• VanderWeele TJ, Hernández-Diaz S. Is there a direct effect of pre-eclampsia on cerebral palsy not through preterm birth? Paediatr Perinat Epidemiol. 2011;25(2):111–115.
   PubMed Web of Science ®Google Scholar
• De Oliveira LG, Diniz ALD, Prado CAC, et al. Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? Rev Bras Ginecol Obstet. 2021;43(1):61–65.
   PubMedGoogle Scholar
• Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285–293.
   PubMed Web of Science ®Google Scholar
• Lin L, Zhu Y, Li B, et al. Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial. Trials. 2018;19(1):608
   PubMedGoogle Scholar
• Leonhardt A, Bernert S, Watzer B, et al. Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics. 2003;111(1):e77–e81.
   PubMed Web of Science ®Google Scholar
• Vlenterie R, Wood ME, Brandlistuen RE, et al. Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study. Int J Epidemiol. 2016;45(6):1998–2008.
   PubMed Web of Science ®Google Scholar
• Larsson KS, Eriksson M. Salicylate-induced fetal death and malformations in two mouse strains. Acta Paediatr Scand. 1966;55(6):569–576.
   PubMed Web of Science ®Google Scholar
• Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev. 2010;20(4):327–348.
   PubMed Web of Science ®Google Scholar
• Elkarmi A, Abu-Samak M, Al-Qaisi K. Modeling the effects of prenatal exposure to aspirin on the postnatal development of rat brain. Growth Dev Aging. 2007;70(1):13–24.
   PubMedGoogle Scholar
• Wu Q, Liu J, Wang X, et al. Organ-on-a-chip: recent breakthroughs and future prospects. Biomed Eng Online. 2020;19(1):9.
   PubMed Web of Science ®Google Scholar